Authors



Maman A. Djauhari

Latest:

Statistical Testing for Outliers: Calculating the Critical Point of the Extreme Studentized Deviation Using the Beta Inverse Function

When analyzing data, you will sometimes find one value that is far from the others. Such a value is called an outlier. When you encounter an outlier, you may be tempted to delete it from the analysis. Assuming that the data point is not attributable to obvious experimental mistakes, do you keep it or delete it?



Gregory T. Bleck

Latest:

Generating a Fully Processed Antibody

The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.



Fiona Greer BP

Latest:

Seeking Accelerated Biosimilar Characterization

The authors describe the qualification of an assay with applications for investigating functional comparability of an originator and biosimilar drug.



David L. Rosen

Latest:

FDA and the Importance of Confidentiality

Do you have to worry about FDA releasing confidential data? Apparently so.



Dan Watson

Latest:

Avoiding the Train Wreck

The "due diligence framework" is an efficient process. But efficient is not the same as quick and easy. There are no shortcuts. The framework minimizes resource commitments and disruptions to ongoing programs and helps each side learn what it needs to know. In six steps, it converts the typical due diligence root canal into a painless filling.


Daniel Alvares Almiñaque

Latest:

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.



John Carlsen

Latest:

Key Considerations in Biosimilars Development

Understanding opportunities and challenges across all major phases of development.


Hsu-Feng Ko

Latest:

Evaluation of Single-Use Fluidized Bed Centrifuge System for Mammalian Cell Harvesting

This article discusses the evaluation of a novel single-use fluidized bed centrifuge for harvesting of antibodies.




Dale Ludwig

Latest:

Development of an Alternative Monoclonal Antibody Polishing Step

MAb polishing using salt tolerant interaction membrane chromatography.


Victor Coker

Latest:

Biotherapeutics Outpace Conventional Therapies

Growth in infrastructure and process-development capabilities will be required to support the biologics market.


Yi Qun Xiao

Latest:

Meeting Challenges for Analysis of Antibody-Drug Conjugates

The complex structure of ADCs necessitates different analytical strategies than those for either small molecules or unconjugated monoclonal antibodies.


Sue Walker

Latest:

Mitigating Risk for Single-Use Assemblies in Sterile Filling

Evaluating the assembly design process, manufacture, and use helps mitigate risk.


Marta Pupo Peña

Latest:

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.


Sian Estdale

Latest:

Key Considerations in Biosimilars Development

Understanding opportunities and challenges across all major phases of development.



Anjan Selz

Latest:

The Drive for Best Practice in Biopharmaceutical Manufacturing

Key business considerations when developing biosimilar products virtually.



Raymond Kaiser

Latest:

Key Considerations in Biosimilars Development

Understanding opportunities and challenges across all major phases of development.


Mehmet Berkmen

Latest:

Oxidative Folding of Proteins in Escherichia Coli

The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins.


Raymond Donninger

Latest:

Key Considerations in Biosimilars Development

Understanding opportunities and challenges across all major phases of development.


Jeffrey T. Macher

Latest:

Correlating Product Lifecycle and Manufacturing Site Characteristics with Product Deviations

MIT survey results address product and site characteristics that statistically correlate with quality performance.


Frederick Doubleday

Latest:

Technology Integration: Enhancing QA and Compliance in Biopharmaceutical Manufacturing

When developing a strategy for using technology in biopharmaceutical manufacturing, include the interaction between automation and business systems and the roles they play in enhancing quality assurance and compliance.

© 2025 MJH Life Sciences

All rights reserved.